Ìåäèöèíñêèå ïåðåâîäû. Ïðîôåññèîíàëüíûå ìåäèöèíñêèå ïåðåâîäû. Ðåäàêòèðîâàíèå ìåäèöèíñêèõ ïåðåâîäîâ. Ìåäèöèíñêèé ïåðåâîä. Áþðî ìåäèöèíñêèõ ïåðåâîäîâ Medtran.

The Multidisciplinary Association for Psychedelic Studies (MAPS) is a membership-based, IRS-approved 501 (c) (3) non-profit research and educational organization. We assist scientists to design, fund, obtain approval for and report on studies into the risks and benefits of MDMA, psychedelic drugs and marijuana. MAPS' mission is to sponsor scientific research designed to develop psychedelics and marijuana into FDA-approved prescription medicines, and to educate the public honestly about the risks and benefits of these drugs. Read our strategy statement for more information. We need your support so together we can make a difference. In addition to general membership donations, MAPS is seeking to raise funds for specific research projects. These are our funding priorities and here are our financial reports.